CORD-19:12d35c12218f230c49f4dc892814ba9f1037f251 / 16879-17067 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/12d35c12218f230c49f4dc892814ba9f1037f251","sourcedb":"CORD-19","sourceid":"12d35c12218f230c49f4dc892814ba9f1037f251","text":"There are several key issues that must be taken into account in order to develop effective CD8 T cell vaccines against respiratory viruses reviewed in detail elsewhere (24-26, 32, 53-56) .","tracks":[{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T77","span":{"begin":0,"end":188},"obj":"Sentence"}],"attributes":[{"subj":"T77","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T77","span":{"begin":0,"end":188},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"TextSentencer_T77","pred":"source","obj":"CORD-19-Sentences"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19_Custom_license_subset","color":"#93dbec","default":true},{"id":"CORD-19-Sentences","color":"#ece393"}]}]}}